Cholera - Annual Epidemiological Report for 2016
Cholera is a rare travel-associated disease in the EU/EEA. In 2016, six EU/EEA countries reported 23 laboratory-confirmed cases of cholera, which was in the range of previous years. All cases with known travel history were infected outside of Europe.
Surveillance systems overview for 2017
This spreadsheet contains all surveillance system overview tables from ECDC's annual epidemiological report for 2017.
- Chlamydia infection
- Crimean-Congo haemorrhagic fever
- Ebola haemorrhagic fever
- hantavirus infection
- healthcare-associated infections
- hepatitis A
- hepatitis B
- hepatitis C
- HIV infection
- invasive Haemophilus influenzae disease
- Lassa fever
- Marburg haemorrhagic fever
- meningococcal disease
- pneumococcal disease
- Q fever
- Rift Valley fever
- severe acute respiratory syndrome
- surgical site infections
- verotoxigenic Escherichia coli infection
- West Nile fever
- yellow fever
Communicable disease threats report, 2-8 December 2018, week 49
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period from 2-8 December 2018 and includes updates on West Nile virus, Ebola virus disease, influenza, poliomyelitis and Middle East respiratory syndrome coronavirus (MERS-CoV).
Best practice recommendations for conducting after-action reviews to enhance public health preparedness
The threat of serious, cross-border infectious disease outbreaks in Europe is a significant challenge in terms of public health emergency preparedness (PHEP). An integral part of improving preparedness and response planning is learning from past experience. Conducting after-action reviews (AARs) on public health emergencies is one such approach, but there is no standardised approach to conducting such assessments. This report identifies the common features of AARs, develops a validity assessment tool for appraising AARs, and proposes a set of best practice recommendations.
Public health guidance in brief on HIV, hepatitis B and C testing in the EU/EEA
The ECDC guidance on integrated testing of hepatitis B (HBV), hepatitis C (HCV) and HIV supports countries in the global effort to combat viral hepatitis and eliminate HIV as public health threats by 2030. At present, reaching and testing those at risk of infection with HIV, HBV or HCV is still a public health challenge across Europe. This Guidance in brief is based on the comprehensive guidance document which provides the evidence base for this guidance
Public health guidance on screening and vaccination for infectious diseases in newly arrived migrants within the EU/EEA
The main objective of this guidance is to provide scientific advice, based on an evidence-based assessment of targeted public health interventions, to facilitate effective screening and vaccination for priority infectious diseases among newly arrived migrant populations to the EU/EEA. It is intended to support EU/EEA Member States to develop national strategies to strengthen infectious disease prevention and control among migrants and meet the health needs of these populations.